LGL Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LGL Partners's MDT Position: Q1 2025 in Review
LGL Partners sold out of Medtronic (MDT) in Q1 2025, closing a stake of 5,326 shares — an estimated $425K sold.
LGL Partners first reported a position in MDT in Q1 2020 and held it in 20 quarters. The position peaked at $585K in Q3 2022. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.
- LGL Partners reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
- LGL Partners sold 5,326 Medtronic shares in Q1 2025, an estimated $425K.
- LGL Partners first reported a position in Medtronic in Q1 2020 and held it in 20 quarters.
- LGL Partners's Medtronic position peaked at $585K in Q3 2022.
- 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.
Based on LGL Partners's 13F filing for Q1 2025, filed 15 May 2025.